NovaBridge Biosciences (NBP) — Financial Flexibility Index
NovaBridge Biosciences (NBP) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of $13.15 Million (operating CF $13.15 Million minus capex $41.00) represents 0% of total liabilities ($131.67 Million). Also explore NovaBridge Biosciences net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NovaBridge Biosciences Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for NovaBridge Biosciences across 8 annual periods. Check NBP capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for NovaBridge Biosciences (2017–2024)
Year-by-year free cash flow to debt coverage for NovaBridge Biosciences. For the full company profile including market capitalisation, see NovaBridge Biosciences (NBP) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.57x | $-52.60 Million | $-52.65 Million | $11.52 Million | ▼ -5521.1% |
| 2023 | -0.08x | $-72.69 Million | $-72.85 Million | $894.81 Million | ▲ +91.8% |
| 2022 | -0.99x | $-1.06 Billion | $-1.10 Billion | $1.07 Billion | ▼ -9.6% |
| 2021 | -0.91x | $-943.16 Million | $-973.09 Million | $1.04 Billion | ▼ -244.9% |
| 2020 | 0.62x | $441.57 Million | $433.56 Million | $706.65 Million | ▲ +375.5% |
| 2019 | -0.23x | $-855.74 Million | $-867.98 Million | $3.77 Billion | ▼ -183.8% |
| 2018 | -0.08x | $-266.30 Million | $-280.70 Million | $3.33 Billion | ▲ +54.3% |
| 2017 | -0.17x | $-231.83 Million | $-252.16 Million | $1.33 Billion | — |